---
title: 'Director, Financial Planning & Analysis at IMVT Corporation'
canonical: 'https://feeny.ai/job/director-financial-planning-analysis-imvt-corporation-remote-2xtk0zhd4zbr'
type: 'job'
last_seen: '2026-10-16'
---

# Director, Financial Planning & Analysis at IMVT Corporation

- **Company:** IMVT Corporation
- **Location:** Remote
- **Compensation:** $200k–$240k
- **Work type:** remote
- **Posted:** 2026-10-12
- **Last confirmed live:** 2026-10-16
- **Apply:** https://job-boards.greenhouse.io/imvtcorporation/jobs/6222689004

## Job description

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs.

The Role:

Reporting to the CFO, this position will have broad financial planning, management reporting, analysis, and business partnership responsibilities. The FP&A team works closely with the CFO and the Leadership Team to develop operating plans and multi-year strategic planning scenarios. This role will serve as the primary finance business partner for Research & Development, owning planning, forecasting, and reporting for the clinical development portfolio and partnering closely with the respective business leaders. The role is responsible for providing timely and accurate financial guidance and analytics to all levels of business partners to inform key decision-making in pursuit of the company’s financial and operational objectives.

As part of the broader financial team at Immunovant, this role will have opportunities for organic learning and development across multiple areas including clinical development and operations, CMC, Investor Relations, Accounting, SEC Reporting, and Commercial, as important stakeholders. We are a small but mighty team, ensuring that our critically important research and development teams are enabled to do their very best work in the interest of our potential patients.

Key Responsibilities:

- In collaboration with business partners, this individual will own development and monitoring of annual budgets, quarterly forecasts, and month-end reporting of actual results for Research & Development
- Support CFO with comprehensive multi-year strategic, financial plan including summarizations to the Board of Directors and executive leadership
- Own trial-level clinical cost models and the key assumptions for all active and planned studies, translating changes in clinical plans and scenarios into budget, forecast, and long-range plan impacts
- Lead the R&D quarterly forecast cycle, including gathering and confirming assumptions with clinical and program leaders, preparing R&D inputs to forecast and Board materials, and supporting parent-company forecast submissions
- Partner with Accounting on R&D month-end close, including review of CRO and clinical trial accrual estimates, budget-to-actual variance analysis, and assessment of timing versus permanent variances
- Partner with Clinical Procurement and Clinical Operations to evaluate CRO and vendor proposals, contracts, and change orders, quantifying risks and opportunities against forecast and cash flow
- Provide business/financial analysis and decision support that allows management to evaluate alternatives, make fact-based decisions, and evaluate the consequences of decisions
- Support CFO with preparation for board and shareholder meetings, periodic executive leadership team meetings, and various strategic initiatives of the company
- Establish meaningful, timely reports, analytics, and financial reviews (including monthly R&D department and program financial reviews) that support business area leaders and enable execution of their priorities
- Build & maintain strong business partnerships through regular meetings and close collaboration to assist in operational and strategic decision-making for business areas, providing candid, solutions-oriented counsel to leadership regarding key decisions and priorities
- Support CFO with business development and financing projects, as needed
- Develop ad hoc analyses and simple, practically useful models to inform leadership team
- Understand and facilitate the integration of business processes, people, and relevant technology, to identify, configure, and communicate useful information, and to provide practical business counsel to support project teams across the company

Requirements:

- 7+ years of relevant experience in financial planning and analysis, investment banking, and / or consulting roles
- Highly motivated with a solutions-oriented, can-do attitude
- Willing to jump in and tackle big and small jobs, as needed
- Strong interpersonal and verbal / written communication skills in a virtual working environment
- Strong learning agility, critical thinking, and analytical skills
- Advanced Excel and complex modeling skills
- Ability to distill complex models and analysis into simple, impactful take-aways
- Ability to meet challenging deadlines in a fast-paced environment without sacrificing results
- Able to work independently with minimal supervision and develop solutions for new problems as they arise
- BA or BS degree required

Preferred:

- MBA or similar Masters
- Experience in biotech or pharmaceuticals industry (ideally supporting R&D, clinical development)
- Experience with Adaptive, Coupa and NetSuite and other planning and reporting tools.

Work Environment:

- Remote-based (East Coast preferred)
- Dynamic, interactive, fast-paced, and entrepreneurial environment
- Domestic or international travel is required (10-20%)

Salary range for posting $200,000—$240,000 USD

Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.

## About IMVT Corporation

## Company Overview
- **One-liner**: A clinical-stage immunology company developing innovative anti-FcRn therapies to enable normal lives for people with autoimmune diseases.
- **Entity Type**: Public (Nasdaq: IMVT)
- **Headquarters**: Durham, North Carolina, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology / Autoimmune disease therapeutics
- **Target customers**: Patients with IgG-mediated autoimmune diseases; healthcare providers; payers (B2B/B2C mix via prescription drugs)
- **Mission or purpose statement**: “Dedicated to enabling normal lives for people with autoimmune diseases” [immunovant.com](https://www.immunovant.com/)

## Products & Services
- **[IMVT-1402 (imeroprubart)]**: A novel, fully human monoclonal antibody that targets FcRn to reduce pathogenic IgG autoantibodies. Designed as a subcutaneous injection with a simple autoinjector (YpsoMate®). In clinical development for six indications: Graves’ disease (GD), difficult-to-treat rheumatoid arthritis (D2T RA), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), Sjögren’s disease (SjD), and cutaneous lupus erythematosus (CLE). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **[Batoclimab (first-generation anti-FcRn)]**: Development discontinued across all indications after Phase 3 TED trials did not meet primary endpoints; learnings inform IMVT-1402 program. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Market Standing
- **Valuation/Market Cap**: Not disclosed in available sources (publicly traded on Nasdaq; refer to real-time market data).
- **Key Metric**: Clinical-stage company with no approved products or revenue; total funding and operating expenses are detailed in SEC filings but not summarized here.
- **Notable Investors/Partners**: HanAll Biopharma (collaboration on anti-FcRn antibodies); Ypsomed AG (auto-injector YpsoMate®). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **Growth Signals**: Six ongoing clinical programs (including potentially registrational trials); deep IgG reductions (~80% with weekly 600 mg IMVT-1402) suggesting best-in-class potential; Phase 1 safety data showing no/minimal albumin reduction or LDL cholesterol increases. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Competitive Advantages
- **Potential best-in-class efficacy**: IMVT-1402 achieves deeper IgG reductions than competitor anti-FcRn antibodies, correlating with improved clinical outcomes.
- **Favorable safety profile**: No or minimal off-target effects on albumin and LDL cholesterol, unlike some FcRn inhibitors.
- **Convenient administration**: Self-administered subcutaneous autoinjector (YpsoMate®) expected at launch, improving patient adherence.
- **Broad pipeline**: Six indications in development across endocrinology, rheumatology, neurology, and dermatology, with potential for more.

## Strategic Focus
- Execute pivotal trials for IMVT-1402 in GD, D2T RA, MG, CIDP, SjD, and CLE.
- Leverage learnings from batoclimab program to accelerate IMVT-1402 development.
- Plan to assess new indications for IMVT-1402 beyond the initial six.
- Continue to build commercial capabilities for eventual launch. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Why Work Here
- **Culture**: Emphasizes “Hire and Retain Only the Very Best,” “One Team, Shared Success,” “Ownership Mentality,” and “Patients Are Waiting” – a mission-driven, high-performance environment. [About Us](https://www.immunovant.com/about-us)
- **Remote/Hybrid Policy**: Job listings show a mix of remote and hybrid roles (e.g., “Remote” for many positions, “Hybrid - NYC” for commercial roles). [Careers](https://www.immunovant.com/join-us/explore-careers)
- **Notable Perks**: Merit-based recognition, focus on impact and results, creative problem-solving encouraged. [About Us](https://www.immunovant.com/about-us)
- **Engineering/Science Culture**: Clinical-stage biotech with cutting-edge FcRn technology; opportunities in clinical development, biometrics, quality assurance, and commercial roles. [Careers](https://www.immunovant.com/join-us/explore-careers)

## Sources
1. [Immunovant Corporate Website](https://www.immunovant.com/)
2. [About Us – Values and Culture](https://www.immunovant.com/about-us)
3. [Company Information – Investor Relations](https://www.immunovant.com/investors/company-information)
4. [Explore Careers – Job Listings](https://www.immunovant.com/join-us/explore-careers)
5. [10-K SEC Filing (May 20, 2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Other roles at IMVT Corporation

- [Senior Manager, Statistical Programming](https://feeny.ai/job/senior-manager-statistical-programming-imvt-corporation-remote-6q5z9h7nwxvn)
- [Executive Assistant](https://feeny.ai/job/executive-assistant-imvt-corporation-new-york-m7dv0wr8rkjs) — New York, NY
- [Senior Director, Biostatistics](https://feeny.ai/job/senior-director-biostatistics-imvt-corporation-remote-swdw529e6zxr)
- [Director, Medical Science Liaison (MSL)](https://feeny.ai/job/director-medical-science-liaison-msl-imvt-corporation-southeast-cnykwbftkpjw) — Southeast, United States
- [Director, Marketing](https://feeny.ai/job/director-marketing-imvt-corporation-remote-4t6kt28mgdh0)
- [Director, Financial Planning & Analysis](https://feeny.ai/job/director-financial-planning-analysis-chartis-chicago-ww00w3ek8ftq) — Chicago, IL
- [Director, Financial Planning & Analysis](https://feeny.ai/job/director-financial-planning-analysis-bda-woodinville-eb6531byhcb3) — Woodinville, WA
- [Director, Financial Planning & Analysis](https://feeny.ai/job/director-financial-planning-analysis-clarify-health-united-states-vtyst9kdqsnq) — United States